Philip Morris Stock Undervalued Despite Strong Shift to Smoke-Free Products

Philip Morris International (PM) is preparing to release its Q1 earnings report, with analyst estimates indicating a potential upside surprise in adjusted earnings per share (EPS). Trefis analysts highlight that the stock remains undervalued relative to its robust cash flows and strategic shift toward smoke-free products like IQOS and ZYN. Historically, PM stock tends to react sharply to earnings releases, potentially providing a tactical short-term trading opportunity. While these smoke-free alternatives continue to drive superior margin expansion, the outlook for the remainder of the year is tempered by limited price growth prospects as the stock nears fair valuation. Overall, a disconnect persists between the company's solid fundamentals and its market valuation ahead of the financial results. The Q1 performance will be a key catalyst in determining if the stock can trigger a near-term rally.